MMSI

Based on Merit Medical Systems, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.

What does Merit Medical Systems do?

Merit Medical Systems designs, manufactures, and markets single-use medical devices for interventional and diagnostic procedures. Its products serve cardiology, radiology, oncology, critical care, and endoscopy settings. The company sells to hospitals and clinical providers through direct sales teams, distributors, and OEM partners in the US and internationally.

Does MMSI pay dividends?

Merit Medical does not currently pay a dividend. The company retains capital to support product development, manufacturing, and potential acquisitions — a common approach for mid-cap medical device companies focused on expanding their procedural product portfolio.

When does MMSI report earnings?

Merit Medical reports earnings on a quarterly cadence, consistent with US-listed public companies. For the exact schedule and most recent results, check the investor relations section of the Merit Medical Systems website.

Is MMSI a good stock to buy?

UQS Score rates MMSI as Below Average overall. The Risk and Valuation pillars are relative strengths, but the Weak Moat and Neutral Quality and Growth ratings temper the overall picture. Investors should review the full pillar breakdown available to UQS Pro members before drawing conclusions.

Is MMSI overvalued?

The UQS Valuation pillar for MMSI is rated Good, suggesting the stock does not appear significantly overpriced relative to its fundamentals and sector peers. That said, valuation is one of five pillars — the complete picture requires reviewing quality, growth, moat, and risk together.

How does MMSI compare to its competitors?

Merit Medical operates in a competitive segment of the medical device market alongside companies like ICU Medical and Stevanato Group. Its focus on single-use interventional and endoscopy products differentiates it from peers with broader platform offerings, though the Weak Moat pillar suggests limited structural advantages over rivals.

What is MMSI's market cap bracket?

Merit Medical Systems is classified as a mid-cap company. This places it in a segment of the market that typically offers more growth potential than large-caps but with greater volatility and less pricing power than the largest medical device manufacturers.

Who founded Merit Medical Systems?

Merit Medical Systems was founded in 1990. For detailed founding history and leadership background, the company's official website and public filings provide comprehensive information.

Is MMSI a long-term quality stock?

As a long-term quality indicator, MMSI's Below Average UQS Score reflects a profile that carries meaningful limitations — particularly the Weak Moat pillar, which raises questions about durable competitive positioning. The Good Risk rating offers some stability, but long-term investors should weigh the full five-pillar analysis available through UQS Pro.

What is the main competitive advantage of Merit Medical?

Merit Medical's breadth of single-use procedural products across multiple clinical specialties — cardiology, radiology, and endoscopy — provides some diversification. However, the UQS Moat pillar rates as Weak, indicating that durable structural advantages relative to competitors are limited at this time.

What sector does MMSI belong to?

Merit Medical Systems operates in the Healthcare sector, specifically within the medical devices and equipment industry. Its products are used in interventional, diagnostic, and therapeutic procedures across hospital and alternate-site clinical settings.

Merit Medical Systems, Inc. has average quality metrics, with room for improvement in margins or capital efficiency.

Merit Medical Systems, Inc. shows steady but unspectacular growth, typical for mature companies.

Merit Medical Systems, Inc. maintains a reasonable risk profile with manageable debt levels.

Merit Medical Systems, Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.

Merit Medical Systems, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for MMSI.

The UQS (Unified Quality Score) for Merit Medical Systems, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Merit Medical Systems, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Merit Medical Systems, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.